Belančić, A. (2020). Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity. Obesity Medicine, 20., 100302. doi: 10.1016/j.obmed.2020.100302
Belančić, Andrej. "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity." Obesity Medicine, vol. 20, 2020, str. 100302. https://doi.org/10.1016/j.obmed.2020.100302
Belančić, Andrej. "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity." Obesity Medicine 20 (2020): 100302. https://doi.org/10.1016/j.obmed.2020.100302
Belančić, A. (2020) 'Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity', Obesity Medicine, 20, str. 100302. doi: 10.1016/j.obmed.2020.100302
Belančić A. Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity. Obesity Medicine [Internet]. 12.2020. [pristupljeno 26.12.2024.];20:100302. doi: 10.1016/j.obmed.2020.100302
A. Belančić, "Gut microbiome dysbiosis and endotoxemia - Additional pathophysiological explanation for increased COVID-19 severity in obesity", Obesity Medicine, vol. 20, str. 100302, Prosinac 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:776025. [Citirano: 26.12.2024.]